(Press-News.org) ROCHESTER, Minn. -- A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians in the October issue of the journal Mayo Clinic Proceedings. Value-based pricing is one potential solution, they write.
VIDEO ALERT: Video of Dr. Rajkumar discussing the commentary is posted on the Mayo Clinic News Network.
Cancer care is not representative of a free-market system, and the traditional checks and balances that make the free-market system work so efficiently in all other areas are absent when it comes to most cancer treatment," write authors, Mustaqeem Siddiqui, M.D., an oncologist and Vincent Rajkumar, M.D., a hematologist.
For example, when it comes to antibiotics to treat a given infection or over-the-counter painkillers, a physician or patient can choose between multiple drugs that do the same thing. But cancer drugs are administered to patients sequentially or in combination, creating a virtual monopoly for each drug. This is one of the principal reasons for the high cost of cancer therapy.
Other factors include the expense of drug development; the high price that patients and insurers are willing to pay for even modest improvement in outcomes; and a lack of regulations such as a cost effectiveness analysis to account for economic and value-based considerations in the drug approval and pricing process, the physicians write.
Solutions the authors recommend include:
Value-based pricing that includes discrete metrics such as an incremental cost effectiveness ratio per quality-adjusted-life-years gained, as a result of a particular treatment. Quality-adjusted-life-years is an estimate of the number of years added to a patient's life by a specific drug intervention, adjusted for quality of life.
A U.S. Food and Drug Administration mandate requiring drug companies to submit a value dossier when seeking drug approval. This information would give patients and physicians the ability to make better-informed decisions about treatment.
Centers for Medicare and Medicaid Services powers to negotiate payments for cancer drugs.
Improved national cancer guidelines providing evidence-based analysis of quality of life, mortality data, benefits, risks and cost for all possible treatment options.
Monopoly rules to determine if a particular drug will operate in a monopoly situation. Such drugs would be subject to legally mandated or voluntary price controls in exchange for expedited approval or other remedy.
Non-profit generic drug companies to manufacture and distribute generic cancer drugs at a very low cost.
###
About Mayo Clinic
Mayo Clinic is a nonprofit worldwide leader in medical care, research and education for people from all walks of life. For more information, visit MayoClinic.com or MayoClinic.org/news.
Mayo Clinic physicians ID reasons for high cost of cancer drugs, prescribe solutions
2012-10-01
ELSE PRESS RELEASES FROM THIS DATE:
Republican strength in congress aids super-rich, president's affiliation has no effect
2012-10-01
WASHINGTON, DC, September 27, 2012 — Republican strength in Congress increases the share of income held by the top 1 percent, but the president's political affiliation has no effect, suggests a new study in the October issue of the American Sociological Review that looks at the rise of the super-rich in the United States.
"This points to the central role that Congress has in the legislative process," said study co-author Thomas W. Volscho, an Assistant Professor of Sociology at CUNY-College of Staten Island. "The president has limited ability to make the sort of legislative ...
Patient-led advocacy has changed how US government funds medical research
2012-10-01
WASHINGTON, DC, September 27, 2012 — Patient-led advocacy has created a shift in the way the U.S. government has prioritized funding for medical research, and significantly changed the way policymakers think about who benefits the most from these dollars, a University of Michigan School of Public Health fellow in the Robert Wood Johnson Foundation Scholars in Health Policy Research Program found.
In "Disease Politics and Medical Research Funding: Three Ways Advocacy Shapes Policy," a paper published in the October issue of the American Sociological Review, Rachel Kahn ...
End your child's allergy suffering within 3 years
2012-10-01
ARLINGTON HEIGHTS, Ill. (October 1, 2012) – When children suffer from dust mite induced allergies and asthma, finding relief can seem impossible. While there isn't a complete cure for childhood respiratory allergies, researchers have found that long term control of allergic asthma can occur after only three years of allergy shots.
According to a new study, published in the October issue of Annals of Allergy, Asthma and Immunology, the scientific publication of the American College of Allergy, Asthma and Immunology (ACAAI), long-term relief can be achieved by administering ...
Radiologists develop evidence-based guidelines to help physicians manage patients with low back pain
2012-10-01
According to an article in the October issue of the Journal of the American College of Radiology, radiologists at Emory University Hospital, in Atlanta, and Georgia Health Sciences University, in Augusta, Ga., have developed evidence-based guidelines to assist physicians with the process of managing patients with acute low back pain. Low back pain is one of the most common reasons for visits to physicians in the outpatient setting.
"The approach to the workup and management of low back pain by physicians and other practitioners is inconstant. In fact, there is significant ...
Hidden stroke impairment leaves thousands suffering in silence
2012-10-01
Most people are completely unaware of one of stroke's most common, debilitating but invisible impairments, according to the first awareness survey of its kind in Canada released today at the Canadian Stroke Congress.
Thirty community volunteers trained by the York-Durham Aphasia Centre, a March of Dimes Canada program, collaborated with researchers from two Ontario universities in a survey of 832 adults in southern Ontario. They found that only two per cent of respondents could correctly identify aphasia as a communication disorder affecting the ability to speak, understand, ...
Special Journal issue focuses on radiology's role in health care reform
2012-10-01
To be published online Monday, Oct. 1, a special issue of the Journal of the American College of Radiology will focus on health policy and radiology's role in health care reform. Topics to be covered include utilization management in radiology, clinical decision support, value-based health care payment systems and patient-centered outcomes in imaging. The October health policy issue was guest edited by Ruth Carlos, MD, MS, FACR, and James Rawson, MD, FACR.
"Health care reform will continue to be a central issue in society regardless of the outcome of the election in ...
'Cafeteria diet' hastens stroke risk
2012-10-01
The fat- and sugar-rich Western diet leads to a lifetime of health problems, dramatically increasing the risk of stroke or death at a younger age, according to a study presented today at the Canadian Stroke Congress.
Researchers found that a high-calorie, high-sugar, high-sodium diet nicknamed the 'cafeteria diet' induced most symptoms of metabolic syndrome – a combination of high levels of cholesterol, blood sugar, blood pressure and obesity – in rats after only two months.
The animals were at an age roughly equivalent to 16 to 22 years in humans at the time of disease ...
Screening for post-stroke depression inadequate and inconsistent, study finds
2012-10-01
Physicians are prescribing anti-depressants for stroke patients without first giving them a proper diagnosis, they are over-treating some patients, and overlooking others, according to a study presented today at the Canadian Stroke Congress.
"A lot of people are being treated for depression, but we don't know if they're the right ones," says lead researcher Ms. Katherine Salter of Parkwood Hospital in London, Ontario. "This study found that 40 per cent of stroke patients were treated for depression, but most were not screened or diagnosed. Who are we treating?"
Researchers ...
Duke Medicine news -- Children underrepresented in drug studies
2012-10-01
DURHAM, N.C. – The number of clinical trials enrolling children is far lower than for adults, and the scope of research is also narrower, according to an analysis of public-access data conducted by researchers at Duke University.
The findings, reported online Oct. 1, 2012, in the journal Pediatrics, quantify an imbalance that has been observed in recent years and highlights an issue that has generated concern among health leaders and policymakers alike.
"Although children comprise one-quarter of the population in the United States, they are greatly underrepresented ...
Many emergency programs get failing grade when it comes to stroke training
2012-10-01
Medical residents training to work in the emergency department need more formal stroke training, says a study presented today at the Canadian Stroke Congress, noting that, as the first point of contact in stroke care, they see nearly 100 per cent of stroke patients taken to hospital.
Researchers surveyed 20 emergency medicine residency programs across Canada and found that very limited lecture time and mandatory on-the-job training are devoted to stroke and neurological care.
Only two of 20 emergency medicine residency programs required on-the-job training in stroke ...